Drug stocks gain;
Drug stocks gained ground Thursday, along with the broader market, as shares of Aastrom Biosciences rallied on news that US regulators are allowing a key stem-cell therapy clinical trial to resume.
Drug stocks slipped in early trading Wednesday while shares of Compugen Ltd. jumped on news that it grossed approximately $20 million through a recent stock sale.